Cell death programs, also known as apoptosis, can trigger herpesviruses to replicate, including any of four known human herpesviruses that can remain latent in their hosts for extended periods, according to Steven Zeichner of Children's National Medical Center and George Washington University in Washington, D.C., and his collaborators. Because so many humans are infected by one or more herpesvirusesincluding cytomegalovirus, oral herpes simplex virus-1 (HSV-1) and genital herpes simplex virus-2 (HSV-2), and Varicella zoster, which causes chicken pox and shingles-this apoptosis-activation pathway could have broad clinical signifıcance. Moreover, it might help to explain some of the side effects of several widely used anticancer drugs, he and his collaborators point out. Details appear in the October 2013 Journal of Virology (87:10641-10650) .
These studies began with Zeichner following up fındings that high concentrations of the antibiotic doxycycline can induce apoptosis and also activate replication by the Kaposi's sarcoma-associated herpesvirus (KSHV). In other words, apoptosis triggers an "alternative replication pathway" for this virus, he says. Similarly, he adds, apoptosis also triggers replication of HSV-1, citing research by his former mentor, Bernard Roizman of the University of Chicago.
"We decided to test . . . several additional human herpesviruses that cause notable diseases and which have good latent infection cell line models, including human herpesvirus (HHV)-6A, -6B, and -7, and Epstein-Barr virus (EBV)," Zeichner says. Several widely used cytotoxic drugs, including doxorubicin and vincristine, act in part by inducing apoptosis of malignant cells. In doing so, they also can activate EBV, KSHV, and several additional herpesviruses, he fınds. Perhaps patients being treated with such drugs, who are harboring latent herpesviruses, also should be treated with antiviral agents, he and his colleagues note.
Additionally, prednisone, a widely used steroid anti-inflammatory agent, may activate latent herpesviruses through apoptosis, according to Zeichner. For example, some patients with Kaposi's sarcoma become worse following treatment with this drug or similar glucocorticoids. Instead of acting via immunosuppression, such drugs might be reactivating KSHV.
"It was intriguing to learn that steroids might activate herpesviruses due to apoptosis instead of immunosuppression, as is widely believed," says Dharam Ablashi of the HHV-6 Foundation in Santa Barbara, Calif. "Perhaps herpesvirus reactivation is responsible for some of the organ failure and severe complications that occur during the late flare of symptoms that occurs in these patients."
Zeichner's report "does not address whether shingles may arise through this mechanism-a fascinating possibility," Ablashi says. Oral and genital herpes may also flare due to apoptosis. In any case, understanding the mechanism of reactivation via apoptosis, he says, "will be the fırst step towards developing novel approaches to treat such conditions in a rational manner."
Amid this interest, several researchers expressed doubts to the HHV-6 Foundation about whether the cell lines used for Zeichner's study carry latent herpesviruses. Sharing those concerns, Ablashi advises Zeichner to redo his experiments with different cell lines. Although Zeichner disagrees, saying the cells that he used contain latent virus and that other researchers report similar fındings, he does plan
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Novel Antimicrobial Candidates
Recent reports on novel antimicrobial candidates include several compounds that are active against drug-resistant strains of bacterial pathogens:
• "Stress-induced mutations quickly increase genetic diversity, enabling subsets of resistant cells to survive and perpetuate their genotype, thereby saving the strain from extinction," Rosenberg continues. Starved Escherichia coli cells, for example, activate the RpoS stress response that allows error-prone polymerases to repair double-strand DNA breaks. The resulting mutation flood accelerates evolution, Rosenberg contends. She speculates that RpoS-promoted mutagenic break repair evolved because of its value as an evolutionary engine.
Error-prone DSB-repair proteins appear to trigger stress-induced mutations in circumstances other than starvation and in organisms other than E. coli. "We know that RpoS programs are induced by osmotic, pH, temperature, and oxidative stresses," says Rosenberg. "We also have evidence that when confronted by antibiotics, E. coli activates RpoS-encoded DSB-repair proteins similar to those used by starved cells, and that pathogenic Salmonella induces RpoS-dependent mutations in response to bile, a membrane irritant." Additionally, Pseudomonas aeruginosa biofılms display a DSB-repair, proteingenerated diversity that she suspects arises by the same mechanisms.
The ability of cells to change rapidly when stressed is also important to tumor progression in hypoxic environments because it provides a way for malignant cells to develop resistance to anti-cancer therapies, according to Rosenberg. She calls for the development of "anti-evolution" drugs that block stress-promoted cellular adaption to host-instigated stressors. These new agents could be combined with conventional antibacterial, antifungal, and anti-cancer drugs, all of which should be classed together as "anti-proliferatives," she says. Details of her arguments appeared August 22, 2012 in Bioessays (34: 885-892; doi:10.1002/ bies.201200050) .
"Rosenberg and colleagues identify specifıc mechanisms enabling bacteria to switch into a hypermutable state, turning up the frequency with which adaptive mutations occur," says Lance Price at George Washington University in Washington, D.C., who was not involved in this research. "More specifically, they explain how the hypermutable state is regulated. It's very cool.
"However, this still feels Darwinian because while the responses to stressors may be specifıc, the mutations themselves appear to be randomly generated," Price continues. "Importantly, the intrinsic ability of bacteria to quickly deal with stress helps explain why exposure to subtherapeutic doses of some antibiotics leads to such rapid evolution of resistant mutants and why the practice has proved so dangerous in
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Recently Noted "Rare" Events of Microbiology
Here are some examples of recently noted rare events in microbiology:
• Plant genes encoding expansins, which weaken cell walls, are a "rare example"
of genes that were transferred from plants to bacteria and fungi, where in some 
